During the past decade, Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research" are "Genetic Diseases, Inborn" (2 trials), "Genetic Diseases, X-Linked" (2 trials), "Muscular Diseases" (2 trials), "Muscular Disorders, Atrophic" (2 trials) and "Muscular Dystrophies" (2 trials). Many other conditions were trialed in "Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research" in a lesser frequency.

Most popular intervention types in "Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ataluren" (2 trials), "Placebo" (2 trials) and "ARO-APOC3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".